Work

Abstract CT059: A phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR1-02 (5-FU-miR-15a) in patients with acute myeloid leukemia

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct059

Authors: Bjørn T. Gjertsen, Andrea Lenartova, Irini Ktoridou-Valen, Cara E. Wogsland, Adam S. Dowrick, Mark Wood, Thomas Dahl, Andrew Fesler, Jingfang Ju

Institutions: University of Bergen, Oslo University Hospital, Stony Brook University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822127

Cites:

Cited by:

Related to: 10